Under Canadian law, the value of the jobs and keeping the plant open more than made up for the difference between the liquidation proceeds from the sale of the plant and the scrap metal value. That is why they went with an offer to continue to operate the plant instead of selling for scrap.
Exactly that!
This is precisely what makes LCY BioSciences, the joint venture between Visolis and LCY Chemical Corp. (now private and owned by KKR), a STRATEGIC BUYER.
And being a Strategic Buyer is precisely what lays the groundwork for any and all agreements under the CCAA, which covers the Canadian subsidiaries BioAmber Sarnia Inc. and BioAmber Canada Inc. The US Parent company is BioAmber Inc. (i.e. where the shares are).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.